Biotechnology is the use of living systems to produce specific products. In pharmaceuticals, this technology is widely used to synthesize complex compounds such as proteins, peptides, antibodies, and recombinant vaccines. Many of these compounds are not only difficult to chemically synthesize, but also require high purity and stability for their production.
Biotechnological methods in the production of complex APIs
- Microbial Fermentation:
- One of the oldest methods in pharmaceutical biotechnology.
- Using bacteria such as E. coli or yeast to produce enzymes, antibiotics, and vitamins.
- Example: Production of penicillin, cephalosporins, and statins.
- Mammalian Cell Culture:
- For the production of complex human proteins such as monoclonal antibodies and coagulation factors.
- Example: Production of drugs such as trastuzumab (Herceptin) or erythropoietin.
- Biocatalysis:
- Using enzymes to carry out selective reactions under mild conditions.
- Advantages: High efficiency, reduced production of unwanted by-products.
- Applications: Synthesis of specific optical isomers, or production of high-precision pharmaceutical intermediates.
- Recombinant DNA Technology:
- Making genetic changes in producer cells to increase yield or improve quality.
- Example: Production of human insulin from genetically modified E. coli.
Advantages of biotechnology over traditional chemical methods
- High selectivity: Enzymes carry out reactions with high molecular precision.
- Mild reaction conditions: low temperature, physiological pH, and lower energy consumption.
- Environmentally friendly: less waste production, reduced need for toxic organic solvents.
- Production of human biological products: The possibility of producing drugs that are completely identical to human proteins with high safety.
Practical applications and outstanding biotechnological products
- Recombinant human insulin: An alternative to animal insulin with higher purity and fewer allergic reactions.
- Anticancer drugs such as ado-trastuzumab: a combination of an antibody and a chemotherapy drug to precisely target cancer cells.
- Recombinant vaccines: Such as the HPV and hepatitis B vaccines, which are produced using cell technology and recombinant DNA.
- Coagulation factors: for hemophilia patients.
- Replacement enzymes in the treatment of rare metabolic diseases.
Biotechnology challenges in API production
- Complexity of the production process: Culturing cells and carefully controlling growth conditions requires advanced infrastructure.
- High cost: Biotechnologies are more expensive than chemical methods, although savings are made in the long run.
- Product stability: Many biologic APIs are unstable and require a cold chain.
- Regulatory and quality considerations: Biologics must be manufactured under strict controls such as cGMP and ICH guidelines (such as Q5A for biostability).
Quality and regulatory standards for biological APIs
- ICH Q11 guideline for the development of biological APIs
- EMA requirements for recombinant substances
- FDA Standards for Biologics (Biologic License Application)
- Tests such as glycosylation, protein purity, viral immunity, and immunogenicity
The future of biotechnology in API production
- Increasing use of stem cells and complex biological systems
- Using CRISPR to optimize cell lines
- Using artificial intelligence in the design of fermentation processes and quality monitoring
- Increasing local production of bio-APIs to reduce dependence on imports
- Building small API production machines in hospital centers for personalized production
Conclusion
Biotechnology is recognized as a powerful scientific and industrial arm in the production of complex and sensitive APIs. By providing precise, green, and adaptable tools, this technology not only enables the production of innovative drugs, but also creates a sustainable and personalized future for drug therapies.
